Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 146 results.
User Information
Export Records
  1. 1.   Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models
  2. Demirci, Selami; Khan,Muhammad; Hinojosa, Gabriela; Le, Anh; Leonard, Alexis; Essawi, Khaled; Gudmundsdottir, Bjorg; Liu, Xiong; Zeng, Jing; Inam, Zaina; Chu, Rebecca; Uchida, Naoya; Araki, Daisuke; London, Evan; Butt, Henna; Maitland, Stacy A; Bauer, Daniel E; Wolfe, Scot A; Larochelle, Andre; Tisdale, John F
  3. Cytotherapy. 2024, Jun ; 26(6): 641-648.
  1. 2.   Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion
  2. Cottrill, Ethan; Pennington, Zach; Wolf,Matthew; Dirckx, Naomi; Ehresman, Jeff; Perdomo-Pantoja, Alexander; Rajkovic, Christian; Lin, Jessica; Maestas, David R; Mageau, Ashlie; Lambrechts, Dennis; Stewart, Veronica; Sciubba, Daniel M; Theodore, Nicholas; Elisseeff, Jennifer H; Witham, Timothy
  3. Journal of Neurosurgery. Spine. 2023, Mar 31; 39(1): 113-121.
  1. 3.   Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice
  2. Hamilton, Betty K; Cutler, Corey; Divine, Clint; Juckett, Mark; LeMaistre, Charles; Stewart, Susan; Wilder, Jennifer; Horowitz, Mary; Khera, Nandita; Burns, Linda J
  3. Transplantation and Cellular Therapy. 2022, May 09;
  1. 4.   TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository
  2. Zhao, Yingdong; Li, Ming-Chung; Konaté, Mariam M; Chen,Li; Das,Biswajit; Karlovich,Chris; Williams,Mickey; Evrard,Yvonne; Doroshow, James H; McShane, Lisa M
  3. Journal of translational medicine. 2021, Jun 22; 19(1): 269.
  1. 5.   Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody
  2. Lee, Myungeun; Lu, Zhi Hong; Shoemaker, Charles B.; Tremblay, Jacqueline M.; St Croix,Brad; Seaman,Steven; Gonzalez-Pastor, Rebeca; Kashentseva, Elena A.; Dmitriev, Igor P.; Curiel, David T.
  3. Journal of Controlled Release : Official Journal of the Controlled Release Society. 2021, Jun 10; 334: 106-113.
  1. 6.   TET2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models
  2. Yang, Sherry X; Hollingshead, Melinda; Rubinstein, Larry; Nguyen, Dat; Larenjeira, Angelo B A; Kinders,Robert; Difilippantonio, Michael; Doroshow, James H
  3. Journal of Hematology & Oncology. 2021, May 26; 14(1):
  1. 7.   Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
  2. Huang, Chen; Chen, Lijun; Savage, Sara R.; Eguez, Rodrigo Vargas; Dou, Yongchao; Li, Yize; Leprevost, Felipe da Veiga; Jaehnig, Eric J.; Lei, Jonathan T.; Wen, Bo; Schnaubelt, Michael; Krug, Karsten; Song, Xiaoyu; Cieslik, Marcin; Chang, Hui-Yin; Wyczalkowski, Matthew A.; Li, Kai; Colaprico, Antonio; Li, Qing Kay; Clark, David J.; Hu, Yingwei; Cao, Liwei; Pan, Jianbo; Wang, Yuefan; Cho, Kyung-Cho; Shi, Zhiao; Liao, Yuxing; Jiang, Wen; Anurag, Meenakshi; Ji, Jiayi; Yoo, Seungyeul; Zhou, Daniel Cui; Liang, Wen-Wei; Wendl, Michael; Vats, Pankaj; Carr, Steven A.; Mani, D. R.; Zhang, Zhen; Qian, Jiang; Chen, Xi S.; Pico, Alexander R.; Wang, Pei; Chinnaiyan, Arul M.; Ketchum, Karen A.; Kinsinger, Christopher R.; Robles, Ana; An, Eunkyung; Hiltke, Tara; Mesri, Mehdi; Thiagarajan,Mathangi; Weaver, Alissa M.; Sikora, Andrew G.; Lubinski, Jan; Wierzbicka, Malgorzata; Wiznerowicz, Maciej; Satpathy, Shankha; Gillette, Michael A.; Miles, George; Ellis, Matthew J.; Omenn, Gilbert S.; Rodriguez, Henry; Boja, Emily S.; Dhanasekaran, Saravana M.; Ding, Li; Nesvizhskii, Alexey; El-Naggar, Adel K.; Chan, Daniel W.; Zhang, Hui; Zhang, Bing
  3. Cancer Cell. 2021, Mar 8; 39(3): 361-379.
  1. 8.   Design and Implementation of the Pre-Clinical DICOM Standard in Multi-Cohort Murine Studies
  2. Kalen,Joseph; Clunie, David A.; Liu,Yanling; Tatum, James L.; Jacobs, Paula M.; Kirby,Justin; Freymann,John; Wagner,Ulli; Smith, Kirk E.; Suloway, Christian; Doroshow, James H.
  3. Tomography. 2021, Mar; 7(1): 1-9.
  1. 9.   Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
  2. Woo, Xing Yi; Giordano, Jessica; Srivastava, Anuj; Zhao, Zi-Ming; Lloyd, Michael W.; de Bruijn, Roebi; Suh, Yun-Suhk; Patidar, Rajesh; Chen,Li; Scherer, Sandra; Bailey, Matthew H.; Yang, Chieh-Hsiang; Cortes-Sanchez, Emilio; Xi, Yuanxin; Wang, Jing; Wickramasinghe, Jayamanna; Kossenkov, Andrew V.; Rebecca, Vito W.; Sun, Hua; Mashl, R. Jay; Davies, Sherri R.; Jeon, Ryan; Frech, Christian; Randjelovic, Jelena; Rosains, Jacqueline; Galimi, Francesco; Bertotti, Andrea; Lafferty, Adam; O'Farrell, Alice C.; Modave, Elodie; Lambrechts, Diether; ter Brugge, Petra; Serra, Violeta; Marangoni, Elisabetta; El Botty, Rania; Kim, Hyunsoo; Kim, Jong-Il; Yang, Han-Kwang; Lee, Charles; Dean, Dennis A.; Davis-Dusenbery, Brandi; Evrard, Yvonne A.; Doroshow, James H.; Welm, Alana L.; Welm, Bryan E.; Lewis, Michael T.; Fang, Bingliang; Roth, Jack A.; Meric-Bernstam, Funda; Herlyn, Meenhard; Davies, Michael A.; Ding, Li; Li, Shunqiang; Govindan, Ramaswamy; Isella, Claudio; Moscow, Jeffrey A.; Trusolino, Livio; Byrne, Annette T.; Jonkers, Jos; Bult, Carol J.; Medico, Enzo; Chuang, Jeffrey H.
  3. Nature Genetics. 2021, Jan; 53(1): 86-99.
  1. 10.   HLA-B Leader and Survivorship after HLA-Mismatched Unrelated Donor Transplantation
  2. Petersdorf, Effie W; Stevenson, Philip; Bengtsson, Mats; De Santis, Dianne; Dubois, Valerie; Gooley, Ted; Horowitz, Mary M; Hsu, Katharine C; Madrigal, Alejandro J; Malkki, Mari; McKallor, Caroline; Morishima, Yasuo; Oudshoorn, Machteld; Spellman, Stephen; Villard, Jean; Carrington,Mary
  3. Blood. 2020, JUL 16; 136(3): 362-369.
  1. 11.   Single cell-derived primary rectal carcinoma cell lines reflect intratumor heterogeneity associated with treatment response
  2. Braun, Rüdiger; Anthuber, Lena; Hirsch, Daniela; Wangsa, Darawalee; Lack,Justin; McNeil, Nicole E; Heselmeyer-Haddad, Kerstin; Torres, Irianna; Wangsa, Danny; Brown, Markus A; Tubbs, Anthony; Auslander, Noam; Gertz, E Michael; Brauer, Philip R; Cam,Maggie; Sackett, Dan; Habermann, Jens K; Nussenzweig, Andre; Ruppin, Eytan; Zhang, Zhongqiu; Rosenberg, Daniel W; Ried, Thomas
  3. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020, JUL; 26(13): 3468-3480.
  1. 12.   Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis
  2. Evrard,Yvonne; Srivastava, Anuj; Randjelovic, Jelena; Consortium, Nci PDXNet; Doroshow, James H; Dean, Dennis A; Morris, Jeffrey S; Chuang, Jeffrey H
  3. Cancer research. 2020, JUN 1; 80(11): 2286-2297.
  1. 13.   Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
  2. Yamamoto, Jun; Murata, Takuya; Sugisawa, Norihiko; Higuchi, Takashi; Tashiro, Yoshihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Shimoya, Koichiro; Nomura, Tsunehisa; Kurebayashi, Junichi; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2475-2479.
  1. 14.   A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model
  2. Lim, Hye In; Yamamoto, Jun; Inubushi, Sachiko; Nishino, Hiroto; Tashiro, Yoshihiko; Sugisawa, Norihiko; Han, Quinhong; Sun, Y U; Choi, Hee Jun; Nam, Seok Jin; Kim, Moon Bo; Lee, Ji Sun; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2481-2485.
  1. 15.   A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
  2. Yamamoto, Jun; Murata, Takuya; Tashiro, Yoshihiko; Higuchi, Takashi; Sugisawa, Norihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Hongo, Atsushi; Nomura, Tsunehisa; Saitoh, Wataru; Moriya, Takuya; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2509-2514.
  1. 16.   Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease
  2. Parta,Mark; Hilligoss, Dianne; Kelly, Corin; Kwatemaa, Nana; Theobald, Narda; Zerbe, Christa S; Holland, Steven M; Malech, Harry L; Kang, Elizabeth M
  3. Journal of clinical immunology. 2020, Apr 20;
  1. 17.   Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Igarashi, Kentaro; Kawaguchi, Kei; Kiyuna, Tasuku; Miyake, Kentaro; Higuchi, Takashi; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Cancer genomics & proteomics. 2020, Jul-Aug; 17(4): 351-358.
  1. 18.   A spontaneously metastatic model of bladder cancer: imaging characterization
  2. Tatum, James L; Kalen,Joseph; Jacobs, Paula M; Ileva,Lilia; Riffle,Lisa; Hollingshead,Melinda; Doroshow, James H
  3. Journal of translational medicine. 2019, Dec 19; 17(1): 425.
  1. 19.   Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model
  2. Park, Jun Ho; Han, Qinghong; Zhao, Ming; Tan, Yuying; Higuchi, Takashi; Yoon, Sang Nam; Sugisawa, Norihiko; Yamamoto, Jun; Bouvet, Michael; Clary, Bryan; Singh,Shree Ram; Hoffman, Robert M
  3. Tissue & cell. 2019, Dec; 61: 109-114.
  1. 20.   The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model
  2. Higuchi, Takashi; Sugisawa, Norihiko; Yamamoto, Jun; Oshiro, Hiromichi; Han, Qinghong; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Tan, Yuying; Kuchipudi, Shreya; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Cancer chemotherapy and pharmacology. 2019, Nov 08;
  1. 21.   Efficacy of oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil on primary colon cancer in a patient-derived orthotopic xenograft mouse model
  2. Park, Jun Ho; Zhao, Ming; Han, Qinghong; Sun, Yu; Higuchi, Takashi; Sugisawa, Norihiko; Yamamoto, Jun; Singh,Shree Ram; Clary, Bryan; Bouvet, Michael; Hoffman, Robert M
  3. Biochemical and biophysical research communications. 2019, Oct 15; 518(2): 306-310.
  1. 22.   Pioglitazone, an agonist of PPAR?, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression
  2. Higuchi, Takashi; Sugisawa, Norihiko; Miyake, Kentaro; Oshiro, Hiromichi; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Kline,Zoey; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019, Oct; 118: 109356.
  1. 23.   Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency: Tandem Liver and Bone Marrow Transplant in DOCK8 Deficiency
  2. Freeman, Alexandra F; Yazigi, Nada; Shah, Nirali N; Kleiner, David E; Parta, Mark; Atkinson, Prescott; Heller, Theo; Holland, Steven M; Kaufman, Stuart S; Khan, Khalid M; Hickstein, Dennis D
  3. Transplantation. 2019, OCT; 103(10): 2144-2149.
  1. 24.   The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model
  2. Miyake, Kentaro; Higuchi, Takashi; Oshiro, Hiromichi; Zhang, Zhiying; Sugisawa, Norihiko; Park, Jun Ho; Razmjooei, Sahar; Katsuya, Yuki; Barangi, Maryam; Li, Yunfeng; Nelson, Scott D; Murakami, Takashi; Homma, Yuki; Hiroshima, Yukihiko; Matsuyama, Ryusei; Bouvet, Michael; Chawla, Sant P; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019, SEP; 117: 109093.
  1. 25.   Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Oshiro, Hiromichi; Tome, Yasunori; Kiyuna, Tasuku; Yoon, Sang Nam; Lwin, Thinzar M; Han, Qinghong; Tan, Yuying; Miyake, Kentaro; Higuchi, Takashi; Sugisawa, Norihiko; Katsuya, Yuki; Park, Jun Ho; Zang, Zhiying; Razmjooei, Sahar; Bouvet, Michael; Clary, Bryan; Singh,Shree Ram; Kanaya, Fuminori; Nishida, Kotaro; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4667-4671.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel